Clover Health is trading at $4.46 (-4.80%) amid a sharp broader-market sell-off. - Major U.S. indexes are falling more than 2.5%, making the market-wide risk-off move the clearest available explanation. - The November 4 earnings report was positive: revenue beat expectations, management raised its 2026 outlook, and Needham reiterated Buy. - No specific company news directly accounting for the drop was identified; these developments do not indicate a company-specific negative catalyst.